Study of Nivolumab in Combination With Ipilimumab Versus to Nivolumab in Combination With Ipilimumab Placebo in Patients With Recurrent or Metastatic Squamous Cell Carcinoma of the Head and Neck

Condition:   Head and Neck Cancer
Interventions:   Biological: Nivolumab;   Biological: Ipilimumab;   Other: Placebo
Sponsor:   Bristol-Myers Squibb
Not yet recruiting - verified July 2016

from #ORL via xlomafota13 on Inoreader http://ift.tt/29hL09J
via IFTTT